HomeInsightsMarket Capitalization

Market Capitalization of Lincoln Pharmaceuticals Ltd

Market Capitalization of Lincoln Pharmaceuticals Ltd

stocks purchased

₹ 0.2 Cr

Volume Transacted

(Dec 12, 2024)

stocks purchased

2.6 K

Stocks Traded

(Dec 12, 2024)

Last Updated on: Dec 12, 2024

Image

Lincoln Pharmaceuticals Ltd

NSE: LINCOLN

Market Cap

₹ 1887.2 crore

Last updated on: Dec 11, 2024

Key Highlights

  • The Market Cap of Lincoln Pharmaceuticals Ltd is ₹ 1887 crore as of 11 Dec 24 .
  • The Market Cap of Lincoln Pharmaceuticals Ltd changed from ₹ 425.1 crore on March 2019 to ₹ 1172 crore on March 2024 . This represents a CAGR of 18.42% over 6 years.
  • The Latest Trading Price of Lincoln Pharmaceuticals Ltd is ₹ 937.05 as of 12 Dec 10:18 .
  • The dividend payouts of Lincoln Pharmaceuticals Ltd changed from ₹ 1.5 to ₹ 1.8 over 6 quarters. This represents a CAGR of 12.92% .

Historical Market Cap of Lincoln Pharmaceuticals Ltd

No data available

* All values are in crore

Company Fundamentals for Lincoln Pharmaceuticals Ltd

No data available

Image

Lincoln Pharmaceuticals Ltd

NSE: LINCOLN

Share Price

₹ 937.05

-5.15 (-0.55%)

stock direction

Last updated on: Dec 12, 2024

Market Price of Lincoln Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Lincoln Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Dec 2024942.2
10 Dec 2024941.4
09 Dec 2024957.35
06 Dec 2024919.9
05 Dec 2024923.25
04 Dec 2024904.9
03 Dec 2024754.1
02 Dec 2024628.45
29 Nov 2024630.45
28 Nov 2024636.6

SWOT Analysis Of Lincoln Pharmaceuticals Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Lincoln Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Lincoln Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Lincoln Pharmaceuticals Ltd

No data available

No data available

Historical P/E Ratio of Lincoln Pharmaceuticals Ltd

No data available

* All values are in %

Historical Revenue of Lincoln Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Lincoln Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Lincoln Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Lincoln Pharmaceuticals Ltd

No data available

* All values are in

About Lincoln Pharmaceuticals Ltd

  • Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. '95.
  • All the assets and business of the erstwhile partnership were transferred to the Company.
  • The Company is engaged in the business of manufacturing and trading of pharmaceutical products.
  • The focused area includes anti-infective, respiratory system, gynecology, cardio & CNS, anti-diabetic, anti malaria, among others. The Company, incorporated in January, 1995, was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982.
  • It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments.

Lincoln Pharmaceuticals Ltd News Hub

News

Lincoln Pharmaceuticals announces board meeting date

Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14...

Read more

07 Nov 2024 14:08

News

Lincoln Pharmaceuticals to conduct AGM

Lincoln Pharmaceuticals announced that the Annual General Meeting (AGM) of the company wil...

Read more

03 Sep 2024 11:39

News

Lincoln Pharmaceuticals AGM scheduled

Lincoln Pharmaceuticals announced that the Annual General Meeting (AGM) of the company wil...

Read more

03 Sep 2024 17:11

News

Lincoln Pharmaceuticals to table results

Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 8 ...

Read more

30 Jul 2024 17:47

News

Board of Lincoln Pharmaceuticals recommends Final Dividend

Lincoln Pharmaceuticals announced that the Board of Directors of the Company at its meetin...

Read more

16 May 2024 12:16

News

Lincoln Pharmaceuticals to announce Quarterly Result

Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 16...

Read more

09 May 2024 10:42

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Lincoln Pharmaceuticals Ltd Market Cap

What is the market cap of Lincoln Pharmaceuticals Ltd?

As of December 12, 2024, Lincoln Pharmaceuticals Ltd has a market capitalization of ₹1887.2, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Lincoln Pharmaceuticals Ltd's market capitalization?

Lincoln Pharmaceuticals Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Lincoln Pharmaceuticals Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Lincoln Pharmaceuticals Ltd's market capitalization change?

Lincoln Pharmaceuticals Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions